Nanopath raises $25 million to support an FDA 510(k) study and manufacturing scale-up for its point-of-care vaginitis assay.
The FDA has approved Promega’s PCR-based OncoMate MSI Dx Analysis System as a companion diagnostic for Merck’s Keytruda.
The nonprofit will act as a liaison between the adrenal insufficiency community and regulators as device makers develop ...
Early data show eectronic genome mapping detected all abnormalities found by standard cytogenetics in blood cancers.
The FDA has cleared BD OneFlow LST and B-CLPD T1 tests for B-cell non-Hodgkin lymphoma, including CLL, enabling US ...
The American Cancer Society now recommends routine PSA-based prostate cancer screening, citing stronger evidence for reduced mortality.
CDC reports early-season influenza activity is above average for November, with H1N1 dominating lab detections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results